Anti-inflammatory activity of water-soluble polysaccharide of Agaricus blazei murill on ovariectomized osteopenic rats

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wang, Peng ^a   Li, Xiao Tao ^b   Sun, Lei ^a   Shen, Lei ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c Qiqihar Medical School   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893788346     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/164817     Document Type: Article

References (29)

1. Michel B. A., Bloch D. A., Fries J. F., Predictors of fractures in early rheumatoid arthritis. Journal of Rheumatology 1991 18 6 804 808 2-s2.0-0025776117
2. Michel B. A., Bloch D. A., Wolfe F., Fries J. F., Fractures in rheumatoid arthritis: an evaluation of associated risk factors (Pubitemid 24017566)
3. Sakurai H., Kohsaka H., Liu M.-F., Higashiyama H., Hirata Y., Kanno K., Saito I., Miyasaka N., Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. Journal of Clinical Investigation 1995 96 5 2357 2363 2-s2.0-0028861879
4. Dijkstra G., Moshage H., van Dullemen H. M., Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease. The Journal of Pathology 1998 186 416 421 (Pubitemid 29005462)
5. Wasser S. P., Weis A. L., Therapeutic effects of substances occurring in higher basidiomycetes mushrooms: a modern perspective. Critical Reviews in Immunology 1999 19 1 65 96 2-s2.0-0032917302 (Pubitemid 29062102)
6. Hsu C.-H., Liao Y.-L., Lin S.-C., Hwang K.-C., Chou P., The mushroom Agaricus blazei Murill in combination with metformin and gliclazide improves insulin resistance in type 2 diabetes: a randomized, double-blinded, and placebo-controlled clinical trial. Journal of Alternative and Complementary Medicine 2007 13 1 97 102 2-s2.0-33847288191 10.1089/acm.2006.6054
7. Han C., Yuan J., Wang Y., Li L., Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. Journal of Trace Elements in Medicine and Biology 2006 20 3 191 196 2-s2.0-33748146443 10.1016/j.jtemb.2006. 06.003 (Pubitemid 44311020)
8. Jiang Y., Zhao J. J., Mitlak B. H., Wang O., Genant H. K., Eriksen E. F., Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. Journal of Bone and Mineral Research 2003 18 11 1932 1941 2-s2.0-0242413030 10.1359/jbmr.2003.18.11.1932 (Pubitemid 37377441)
9. Laight D. W., Gunnarsson P. T., Kaw A. V., Änggård E. E., Carrier M. J., Physiological microassay of plasma total antioxidant status in a model of endothelial dysfunction in the rat following experimental oxidant stress in vivo. Environmental Toxicology and Pharmacology 1999 7 1 27 31 2-s2.0-0033049439 10.1016/S1382-6689(98)00046-5 (Pubitemid 29134928)
10. Peck W. A., Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. American Journal of Medicine 1993 94 6 646 650 2-s2.0-0027222768 10.1016/0002-9343(93)90218-E (Pubitemid 23166713)
11. Johnell O., Kanis J., Epidemiology of osteoporotic fractures. Osteoporosis International 2005 16 2 S3 S7 2-s2.0-26944458929 10.1007/s00198-004-1702-6 (Pubitemid 46232115)
12. Rizzoli R., Reginster J.-Y., Adverse drug reactions to osteoporosis treatments. Expert Review of Clinical Pharmacology 2011 4 5 593 604 2-s2.0-80052703010 10.1586/ecp.11.42
13. Vaca C. E., Wilhelm J., Harms-Ringdahl M., Interaction of lipid peroxidation products with DNA. A review. Mutation Research 1988 195 2 137 149 2-s2.0-0023841337 (Pubitemid 18066067)
14. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979 95 2 351 358 2-s2.0-0018384650 (Pubitemid 9194347)
15. Will R., Palmer R., Bhalla A. K., Ring F., Calin A., Osteoporosis in early ankylosing spondylitis: a primary pathological event? The Lancet 1989 2 8678-8679 1483 1485 2-s2.0-0024810864 (Pubitemid 20018143)
16. Pfeilschifter J., Wuster C., Vogel M., Enderes B., Ziegler R., Minne H. W., Inflammation-mediated osteopenia (IMO) during acute inflammation in rats is due to a transient inhibition of bone formation. Calcified Tissue International 1987 41 6 321 325 2-s2.0-0023612977
17. Armour K. E., van't Hof R. J., Grabowski P. S., Reid D. M., Ralston S. H., Evidence for a pathogenic role of nitric oxide in inflammation-induced osteoporosis. Journal of Bone and Mineral Research 1999 14 12 2137 2142 2-s2.0-0033392377 (Pubitemid 30026963)
18. Armour K. J., Armour K. E., van't Hof R. J., Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis & Rheumatism 2001 44 2790 2796 (Pubitemid 34016198)
19. Sass G., Heinlein S., Agli A., Bang R., Schümann J., Tiegs G., Cytokine expression in three mouse models of experimental hepatitis. Cytokine 2002 19 3 115 120 2-s2.0-0036401433 10.1006/cyto.2002.1948 (Pubitemid 35216191)
20. Jaruga B., Hong F., Kim W.-H., Gao B., IFN- γ /STAT1 acts as a proinflammatory signal in T cell-mediated hepatitis via induction of multiple chemokines and adhesion molecules: a critical role of IRF-1. American Journal of Physiology-Gastrointestinal and Liver Physiology 2004 287 5 G1044 G1052 2-s2.0-7044235774 10.1152/ajpgi.00184.2004 (Pubitemid 39423697)
21. Fujikura S., Mizuhara H., Miyazawa Y., Fujiwara H., Kaneda K., Kinetics and localization of lymphoblasts that proliferate in the murine liver after concanavalin a administration. Biomedical Research 1996 17 2 129 139 2-s2.0-0029994520 (Pubitemid 26182179)
22. Mandai M., Yoshimura N., Yoshida M., Iwaki M., Honda Y., The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG -nitro L-arginine. Investigative Ophthalmology and Visual Science 1994 35 10 3673 3680 2-s2.0-0028046452 (Pubitemid 24337980)
23. Endres S., Fülle H.-J., Sinha B., Stoll D., Dinarello C. A., Gerzer R., Weber P. C., Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor- α and interleukin-1 β by human mononuclear cells. Immunology 1991 72 1 56 60 2-s2.0-0026026007
24. Guo J.-Y., Li C.-Y., Ruan Y.-P., Sun M., Qi X.-L., Zhao B.-S., Luo F., Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain. European Journal of Pharmacology 2009 612 1-3 54 60 2-s2.0-65549129726 10.1016/j.ejphar.2009.03.076
25. Zingarelli B., Sheehan M., Wong H. R., Nuclear factor- B as a therapeutic target in critical care medicine. Critical Care Medicine 2003 31 1 S105 S111 2-s2.0-0037247748 (Pubitemid 36143484)
26. Wertheimer S. J., Myers C. L., Wallace R. W., Parks T. P., Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor- α and phorbol myristate acetate. Journal of Biological Chemistry 1992 267 17 12030 12035 2-s2.0-0026710624
27. Krempien B., Vukicevic S., Vogel M., Stavljenic A., Buchele R., Cellular basis of inflammation-induced osteopenia in growing rats. Journal of Bone and Mineral Research 1988 3 5 573 582 2-s2.0-0023680635
28. Iotsova V., Caamaño J., Loy J., Yang Y., Lewin A., Bravo R., Osteopetrosis in mice lacking NF- B1 and NF- B2. Nature Medicine 1997 3 11 1285 1289 2-s2.0-0030715563
29. Novack D. V., Role of NF- B in the skeleton. Cell Research 2011 21 1 169 182 2-s2.0-78650858041 10.1038/cr.2010.159